Medications are the most commonly implicated cause of bradykinin-mediated angioedema [1]. Angiotensin-converting enzyme inhibitors (ACEi) are the classical causative agent and the most common, followed by non-steroidal anti-inflammatory drugs [2]. The gene discussed is KNG1; the disease is angioedema.